This weekSeptember 26, 2026
RWANDA’S MERRIMACK INVESTMENT: WHAT DID THE PUBLIC RECEIVE?
Rwanda's public health-insurance institutions invested in a US biotechnology company. A minister reported US$3 million in dividends, but did the country recover its principal?
Read this week’s article